Scigen Company

SciGen is a high growth biopharmaceutical company that develops, manufactures and markets recombinant human health care biotechnology derived products. SciGen's focus is in the areas of endocrinology, gastroenterology and immunology. The company’s portfolio consists of biosimilar products such as rhuman growth hormone, rhuman insulin and rhuman GCSF. All of SciGen’s products have undergone substantial clinical development.
SciGen’s strategy is to focus on biosimilars (follow-on proteins) in order to minimize the risk of early stage product development. SciGen also collaborates with strategic partners and institutions in order to continuously fill & improve its pipeline.
SciGen also in-licenses and distributes pharmaceutical products and medical devices.
Technology: Drug Discovery
Industry: Personalized Medicine
Funding Status: N/A

Visit Website
Register and Claim Ownership